Aspire Biopharma Holdings, Inc. Gains 64.35%
Mon, Aug 18, 2025 at 07:43 PM
Aspire Biopharma Holdings, Inc. (ASBP:NASDAQ) shot up at $0.59, a gain of 64.3%. On Mon, Aug 18, 2025, ASBP:NASDAQ touched a New 2-Week High of $0.59. The stock appeared on our News Catalysts scanner on Mon, Aug 18, 2025 at 08:58 AM in the 'BIOTECH' category. From Mon, Aug 04, 2025, the stock recorded 40.00% Up Days and 18.18% Green Days
The stock spiked on Mon, Aug 18, 2025 at $0.88 with a volume of 463M+.
About Aspire Biopharma Holdings, Inc. (ASBP:NASDAQ)
Aspire Biopharma is developing next generation absorption of medicine that will have a significant impact on the opioid crisis.
Top 10 Gainers:
- Hempacco Co., Inc. (HPCO:NASDAQ), 350%
- Soligenix, Inc. (SNGX:NASDAQ), 78.42%
- Aspire Biopharma Holdings, Inc. (ASBP:NASDAQ), 64.35%
- Catheter Precision, Inc. (VTAK:NYSEMKT), 62.84%
- ALX Oncology Holdings Inc. (ALXO:NASDAQ), 50.69%
- Xunlei Limited (XNET:NASDAQ), 37.56%
- GoodRx Holdings, Inc. (GDRX:NASDAQ), 37.27%
- Burning Rock Biotech Limited (BNR:NASDAQ), 35.96%
- ImmunoPrecise Antibodies Ltd. (IPA:NASDAQ), 35%
- Iron Horse Acquisitions Corp. (IROH:NASDAQ), 29.86%